This information was published on 2025-12-18T04:49:23 for IP Right Filed Published.
| Field | Value |
| (210) | 2613396 (IR 1893076) |
| (220) |
28 Aug 2025
|
| (300) |
US, 11 Jul 2025, 99279029
|
| (511) (510) |
Class 1
Chemical compounds in the nature of nucleotides for scientific and research use; chemical compounds in the nature of nucleotides for use in the manufacture of pharmaceuticals. Class 5 Pharmaceutical preparations, namely, RNA-based therapeutics for use in the treatment of complement-mediated, immune-related, genetic, cardiovascular, central nervous system, and metabolic diseases, conditions, and disorders, and cancer. Class 42 Development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical research and development; scientific research and development in the field of RNA-based therapeutics; design and testing of RNA agents; bioinformatics and genomic data analysis for therapeutic development. |
| (540) | ADARX PHARMACEUTICALS |
| (550) | Word |
| (730) |
ADARX PHARMACEUTICALS, INC.
|
Find out more about publications on the About page.